Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AGGRASTAT
- Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke
- Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)
- Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI.
- Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
- Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
- Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
- Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention
- Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients
- Safety of High-dose Tirofiban During Coronary Angioplasty
- FATA: Randomized Study on Facilitated Angioplasty With Tirofiban or Abciximab
- Treating Acute MI Patients With Aggrastat on Their Way to Hospital
- Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)
Clinical trials list
click for details